MELISSA TODD: Open Payments
NPI 1821471079 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 22 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $70 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $236 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $120 |
| Abbott Laboratories | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| Lilly USA, LLC | 3 | $49 |
| ABBVIE INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $21 |
Products named: Wegovy, Kerendia, JARDIANCE, ID NOW STREP A 2, AIRSUPRA, UBRELVY, LEQVIO, REZDIFFRA.
Industry payments across KY — which companies pay providers there.
